BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 34029777)

  • 1. Crohn's-like Enteritis in X-Linked Agammaglobulinemia: A Case Series and Systematic Review.
    Khan F; Person H; Dekio F; Ogawa M; Ho HE; Dunkin D; Secord E; Cunningham-Rundles C; Ward SC
    J Allergy Clin Immunol Pract; 2021 Sep; 9(9):3466-3478. PubMed ID: 34029777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrointestinal Manifestations in X-linked Agammaglobulinemia.
    Barmettler S; Otani IM; Minhas J; Abraham RS; Chang Y; Dorsey MJ; Ballas ZK; Bonilla FA; Ochs HD; Walter JE
    J Clin Immunol; 2017 Apr; 37(3):287-294. PubMed ID: 28236219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute primary purulent pericarditis in an adult patient with unknown X-linked agammaglobulinemia.
    Martignani C; Massaro G; Bruno AG; Biffi M; Ziacchi M; Diemberger I
    Immunobiology; 2020 Jan; 225(1):151861. PubMed ID: 31740078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case Report: A Case of X-Linked Agammaglobulinemia With High Serum IgE Levels and Allergic Rhinitis.
    Cinicola B; Uva A; Leonardi L; Moratto D; Giliani S; Carsetti R; Ferrari S; Zicari AM; Duse M
    Front Immunol; 2020; 11():582376. PubMed ID: 33224144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Genetic Study of X-linked Agammaglobulinemia Patients (The Benefit of Early Diagnosis).
    Alizadeh Z; Dashti P; Mazinani M; Nourizadeh M; Shakerian L; Tajik S; Movahedi M; Mamishi S; Pourpak Z; Fazlollahi MR
    Iran J Allergy Asthma Immunol; 2020 Jun; 19(3):305-309. PubMed ID: 32615664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity and inflammation in X-linked agammaglobulinemia.
    Hernandez-Trujillo VP; Scalchunes C; Cunningham-Rundles C; Ochs HD; Bonilla FA; Paris K; Yel L; Sullivan KE
    J Clin Immunol; 2014 Aug; 34(6):627-32. PubMed ID: 24909997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.
    Rivière JG; Franco-Jarava C; Martínez-Gallo M; Aguiló-Cucurull A; Blasco-Pérez L; Paramonov I; Antolín M; Martín-Nalda A; Soler-Palacín P; Colobran R
    Front Immunol; 2020; 11():46. PubMed ID: 32117230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical characteristics and prenatal diagnosis for 22 families in Henan Province of China with X-linked agammaglobulinemia (XLA) related to Bruton's tyrosine kinase (BTK) gene mutations.
    Gao S; Hu S; Duan H; Wang L; Kong X
    BMC Med Genet; 2020 Jun; 21(1):131. PubMed ID: 32552675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked agammaglobulinemia - first case with Bruton tyrosine kinase mutation from Pakistan.
    Zaidi SK; Qureshi S; Qamar FN
    J Pak Med Assoc; 2017 Mar; 67(3):471-473. PubMed ID: 28304004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Registry Study of 240 Patients with X-Linked Agammaglobulinemia Living in the USA.
    Hernandez-Trujillo V; Zhou C; Scalchunes C; Ochs HD; Sullivan KE; Cunningham-Rundles C; Fuleihan RL; Bonilla FA; Petrovic A; Rawlings DJ; de la Morena MT
    J Clin Immunol; 2023 Aug; 43(6):1468-1477. PubMed ID: 37219739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed diagnosis of X-linked agammaglobulinaemia in a boy with recurrent meningitis.
    Zhang YN; Gao YY; Yang SD; Cao BB; Zheng KL; Wei P; Chen LF; Chen WX
    BMC Neurol; 2019 Dec; 19(1):320. PubMed ID: 31830942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct Clinical Features and Novel Mutations in Taiwanese Patients With X-Linked Agammaglobulinemia.
    Yeh YH; Hsieh MY; Lee WI; Huang JL; Chen LC; Yeh KW; Ou LS; Yao TC; Wu CY; Lin SJ
    Front Immunol; 2020; 11():2001. PubMed ID: 33013854
    [No Abstract]   [Full Text] [Related]  

  • 13. IgA nephropathy in a child with X-linked agammaglobulinemia: a case report.
    Song Y; Sun L; Feng D; Sun Q; Wang Y
    BMC Pediatr; 2024 Apr; 24(1):291. PubMed ID: 38689221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vedolizumab treatment in a patient with X-linked agammaglobulinemia, is it safe and efficient?
    Çekiç Ş; Özgür T; Karalı Y; Özkan T; Kılıç SŞ
    Turk J Pediatr; 2019; 61(6):937-940. PubMed ID: 32134589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastatic colorectal cancer and severe hypocalcemia following irinotecan administration in a patient with X-linked agammaglobulinemia: a case report.
    Li M; Chen W; Sun X; Wang Z; Zou X; Wei H; Wang Z; Chen W
    BMC Med Genet; 2019 Sep; 20(1):157. PubMed ID: 31510946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication.
    Nunes-Santos CJ; Koh C; Rai A; Sacco K; Marciano BE; Kleiner DE; Marko J; Bergerson JRE; Stack M; Rivera MM; Constantine G; Strober W; Uzel G; Fuss IJ; Notarangelo LD; Holland SM; Rosenzweig SD; Heller T
    J Allergy Clin Immunol; 2022 Jan; 149(1):400-409.e3. PubMed ID: 34087243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. X-Linked Agammaglobulinemia With Chronic Meningoencephalitis: A Diagnostic Challenge.
    Saini AG; Radotra BD; Bhattarai D; Rawat A; Bhatia V
    Indian Pediatr; 2021 Feb; 58(2):169-173. PubMed ID: 33632949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastrointestinal disorders next to respiratory infections as leading symptoms of X-linked agammaglobulinemia in children - 34-year experience of a single center.
    Pac M; Bernatowska EA; Kierkuś J; Ryżko JP; Cielecka-Kuszyk J; Jackowska T; Mikołuć B
    Arch Med Sci; 2017 Mar; 13(2):412-417. PubMed ID: 28261296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical X-linked agammaglobulinaemia caused by a novel BTK mutation in a selective immunoglobulin M deficiency patient.
    Lim LM; Chang JM; Wang IF; Chang WC; Hwang DY; Chen HC
    BMC Pediatr; 2013 Sep; 13():150. PubMed ID: 24074005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed diagnosis in X-linked agammaglobulinemia and its relationship to the occurrence of mutations in BTK non-kinase domains.
    Carrillo-Tapia E; García-García E; Herrera-González NE; Yamazaki-Nakashimada MA; Staines-Boone AT; Segura-Mendez NH; Scheffler-Mendoza SC; O Farrill-Romanillos P; Gonzalez-Serrano ME; Rodriguez-Alba JC; Santos-Argumedo L; Berron-Ruiz L; Sanchez-Flores A; López-Herrera G
    Expert Rev Clin Immunol; 2018 Jan; 14(1):83-93. PubMed ID: 29202590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.